Complete Hemp/Cannabis Solution from Receptor Science and Plant Genetics to Final Ingredients and CDMO
Consistent, Reliable, High-Quality Cannabinoids and Cannabinoid Infused Products for Consumers
Acquisition
22nd Century Group, Inc. (NASDAQ: XXII) announced the acquisition of privately held GVB Biopharma.
GVB - a contract development and manufacturing organization - provides hemp-derived active ingredients for the pharmaceutical and consumer goods industries worldwide.
Companies Reporting Before The Bell
• Mirum Pharmaceuticals (NASDAQ:MIRM) is expected to report quarterly loss at $1.34 per share on revenue of $8.46 million.